宫内心脏介入治疗胎儿危重型先天性心脏病5例报告

doi:10.12372/jcp.2024.22e1355

临床儿科杂志 ›› 2024, Vol. 42 ›› Issue (1): 35-39.doi: 10.12372/jcp.2024.22e1355

宫内心脏介入治疗胎儿危重型先天性心脏病5例报告

蔡蕾裔¹, 赵莉晴¹, 王磊², 焦先婷¹, 张拥军³, 武育蓉¹, 朱泓², 夏红萍³, 孙锟¹, 陈笋¹()

1.儿心脏中心，上海交通大学医学院附属新华医院（上海 200092）
2.宫内儿科疾病诊治中心，上海交通大学医学院附属新华医院（上海 200092）
3.新生儿科，上海交通大学医学院附属新华医院（上海 200092）

收稿日期:2022-10-11 出版日期:2024-01-15 发布日期:2024-01-05
通讯作者: 陈笋 E-mail:chensun@xinhuamed.com.cn
基金资助:
上海市卫健委项目(202040160);上海市卫健委项目(20214Y0126)

Fetal cardiac intervention for critical congenital heart disease of fetus: a report of 5 cases

CAI Leiyi¹, ZHAO Liqing¹, WANG Lei², JIAO Xianting¹, ZHANG Yongjun³, WU Yurong¹, ZHU Hong², XIA Hongping³, SUN Kun¹, CHEN Sun¹()

1. Pediatric Heart Center, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
2. Intrauterine Pediatric Disease Diagnosis and Treatment Center, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
3. Neonatology Department, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Received:2022-10-11 Published:2024-01-15 Online:2024-01-05
Contact: CHEN Sun E-mail:chensun@xinhuamed.com.cn

摘要/Abstract

摘要：

目的探索胎儿心脏介入治疗（FCI）对于胎儿危重型先天性心脏病的可行性及短期疗效。方法纳入2018年8月至2022年5月在宫内诊治中心进行FCI的所有患儿的临床资料，包括围产期至出生后基本信息、FCI手术信息、胎儿超声心动图信息等，追踪病例至出生后3月，分析FCI技术的可行性、有效性及安全性。结果纳入胎儿7例，其中5例实施FCI手术，手术成功率100%（5/5），包括2例重度主动脉瓣狭窄（CAS）和3例室间隔完整型肺动脉闭锁（PA/IVS）。手术时的中位孕周为29⁺²（28⁺⁶~32⁺⁴）周。5例胎儿FCI术后的超声心动图指标均获得明显改善。5例胎儿均足月出生，中位出生胎龄39⁺²（38~39⁺⁴）周。生后2例CAS患儿行外科主动脉瓣成形术，3例PA/IVS患儿完成经皮肺动脉瓣球囊扩张术。1例心功能不全CAS患儿于新生儿期死亡，4例随访中，预后良好。结论 FCI是一项安全、有效的技术，有望改善危重型先天性心脏病的预后。

关键词: 胎儿心脏介入治疗, 主动脉瓣狭窄, 室间隔完整型肺动脉闭锁, 先天性心脏病

Abstract:

Objective To explore the feasibility and short-term efficacy of fetal cardiac intervention (FCI) for critical congenital heart disease. Methods The clinical data of all the fetuses who underwent FCI in the intrauterine diagnosis and treatment center from August 2018 to May 2022 were included, including basic information from perinatal to postnatal, FCI surgical information, fetal echocardiogram information, etc., and the fetuses were followed up until 3 months after birth to analyze the feasibility, effectiveness and safety of FCI technology. Results Seven fetuses were included, 5 of whom underwent FCI surgery with a 100% success rate (5/5), including 2 cases of critical aortic stenosis (CAS) and 3 cases of pulmonary atresia with intact ventricular septum (PA/IVS). The median gestational age at the time of FCI surgery was 29⁺²(28⁺⁶-32⁺⁴) weeks. The echocardiographic indexes of 5 fetuses after FCI were significantly improved. All five fetuses were full-term, with a median gestational age of 39⁺²(38-39⁺⁴) weeks. After birth, aortic valvuloplasty was performed in 2 patients with CAS and percutaneous balloon dilatation of pulmonary valve was performed in 3 patients with PA/IVS. One case of CAS with cardiac insufficiency died in the neonatal period, and the other 4 cases had good prognosis during follow-up. Conclusion FCI is a safe and effective technique that is expected to improve the prognosis of critical congenital heart disease.

Key words: fetal cardiac intervention, aortic stenosis, pulmonary atresia with intact ventricular septum, congenital heart disease

蔡蕾裔, 赵莉晴, 王磊, 焦先婷, 张拥军, 武育蓉, 朱泓, 夏红萍, 孙锟, 陈笋. 宫内心脏介入治疗胎儿危重型先天性心脏病5例报告[J]. 临床儿科杂志, 2024, 42(1): 35-39.

CAI Leiyi, ZHAO Liqing, WANG Lei, JIAO Xianting, ZHANG Yongjun, WU Yurong, ZHU Hong, XIA Hongping, SUN Kun, CHEN Sun. Fetal cardiac intervention for critical congenital heart disease of fetus: a report of 5 cases[J]. Journal of Clinical Pediatrics, 2024, 42(1): 35-39.

图/表 3

参考文献 17

[1]	Rosano A, Botto L D, Botting B, et al. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective[J]. Journal of Epidemiology and Community Health, 2000, 54(9): 660-666. doi: 10.1136/jech.54.9.660 pmid: 10942444
[2]	Zhang X, Sun Y, Zhu J, et al. Epidemiology, prenatal diagnosis, and neonatal outcomes of congenital heart defects in eastern China: a hospital-based multicenter study[J]. BMC Pediatr, 2020, 20(1): 416. doi: 10.1186/s12887-020-02313-4 pmid: 32878605
[3]	Arzt W, Tulzer G, Aigner M, et al. Invasive intrauterine treatment of pulmonary atresia/intact ventricular septum with heart failure[J]. Ultrasound Obstet Gynecol, 2003, 21(2): 186-188. doi: 10.1002/uog.v21:2
[4]	Tworetzky W, Marshall AC. Fetal interventions for cardiac defects[J]. Pediatr Clin North Am, 2004, 51(6): 1503-1513. doi: 10.1016/j.pcl.2004.08.005
[5]	Freud LR, Tworetzky W. Fetal interventions for congenital heart disease[J]. Curr Opin Pediatr, 2016, 28(2): 156-162. doi: 10.1097/MOP.0000000000000331 pmid: 26886784
[6]	Friedman KG, Tworetzky W. Fetal cardiac interventions: Where do we stand?[J]. Arch Cardiovasc Dis, 2020, 113(2): 121-128. doi: S1875-2136(19)30138-X pmid: 32113817
[7]	McElhinney DB, Marshall AC, Wilkins-Haug LE, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome[J]. Circulation, 2009, 120(15): 1482-1490. doi: 10.1161/CIRCULATIONAHA.109.848994 pmid: 19786635
[8]	Hogan WJ, Grinenco S, Armstrong A, et al. Fetal cardiac intervention for pulmonary atresia with intact ventricular septum: international fetal cardiac intervention registry[J]. Fetal Diagn Ther, 2020: 1-9.
[9]	Tworetzky W, McElhinney DB, Marx GR, et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes[J]. Pediatrics, 2009, 124(3): e510-e518. doi: 10.1542/peds.2008-2014
[10]	Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association[J]. Circulation, 2014, 129(21): 2183-2242. doi: 10.1161/01.cir.0000437597.44550.5d pmid: 24763516
[11]	International Society of Ultrasound in Obstetrics and Gynecology, Carvalho JS, Allan LD, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart[J]. Ultrasound Obstet Gynecol, 2013, 41(3): 348-359. doi: 10.1002/uog.12403 pmid: 23460196
[12]	Maxwell D, Allan L, Tynan MJ. Balloon dilatation of the aortic valve in the fetus: a report of two cases[J]. Br Heart J, 1991, 65(5): 256-258. pmid: 2039669
[13]	Tulzer A, Arzt W, Tulzer G. Fetal aortic valvuloplasty may rescue fetuses with critical aortic stenosis and hydrops[J]. Ultrasound Obstet Gynecol, 2021, 57(1): 119-125. doi: 10.1002/uog.v57.1
[14]	Araujo Júnior E, Tonni G, Chung M, et al. Perinatal outcomes and intrauterine complications following fetal intervention for congenital heart disease: systematic review and meta-analysis of observational studies[J]. Ultrasound Obstet Gynecol, 2016, 48(4): 426-433. doi: 10.1002/uog.15867 pmid: 26799734
[15]	Salvin JW, McElhinney DB, Colan SD, et al. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum[J]. Pediatrics, 2006, 118(2): e415-e420. doi: 10.1542/peds.2006-0428 pmid: 16882782
[16]	赵莉晴, 陈笋, 武育蓉, 等. 经皮心导管微导丝肺动脉瓣打孔并球囊扩张治疗新生儿室间隔完整型肺动脉瓣闭锁效果分析[J]. 中华儿科杂志, 2020, 58(2): 96-100.
[17]	McElhinney DB, Tworetzky W, Lock JE. Current status of fetal cardiac intervention[J]. Circulation, 2010, 121(10): 1256-1263. doi: 10.1161/CIRCULATIONAHA.109.870246 pmid: 20231543

病例	年龄/岁	孕产史	主要诊断	首诊孕周/周	术时孕周/周	出生胎龄/周	出生体重/g	生后结局
例1	35	G3P1	CAS	24⁺⁵	32⁺³	38⁺³	3 980	FU
例2	32	G3P0	CAS	28⁺⁴	28⁺⁶	38⁺⁰	2 710	NND
例3	35	G3P1	PA/IVS	22⁺⁵	32⁺⁴	39⁺⁴	4 160	FU
例4	29	G2P0	PA/IVS	24⁺²	28⁺⁶	39⁺²	3 260	FU
例5	34	G6P0	PA/IVS	26⁺⁰	28⁺³	39⁺³	3 050	FU

宫内心脏介入治疗胎儿危重型先天性心脏病5例报告

Fetal cardiac intervention for critical congenital heart disease of fetus: a report of 5 cases

RichHTML

PDF (PC)

赞

可视化

被引次数

摘要/Abstract

引用本文

使用本文

图/表 3

参考文献 17

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	王慧颖, 唐嘉忠, 尚文媛, 黄继红, 鲁亚南, 陈笋. 先天性心脏病术后机械通气时间影响的因素分析[J]. 临床儿科杂志, 2024, 42(7): 654-658.
[2]	汪莉波, 张倩文, 姚如恩, 唐怡珺, 高诗阳, 李智颖, 胡斐涵, 李辛, 娄丹, 王秀敏. 5例17p13.3微缺失综合征临床特征分析及疗效评价[J]. 临床儿科杂志, 2024, 42(11): 942-947.
[3]	陈笋. 先天性心脏病宫内介入治疗现状与展望[J]. 临床儿科杂志, 2024, 42(10): 833-836.
[4]	汪思园, 陈瑜, 孙梦莲, 何晓敏, 黄坚鹄, 沈南平. ≤1岁先天性心脏病患儿体外循环术后脑氧去饱和事件危险因素分析[J]. 临床儿科杂志, 2024, 42(10): 843-848.
[5]	阮雪华, 孙晶, 孙锟. 环境相关因素与先天性心脏病研究进展[J]. 临床儿科杂志, 2023, 41(3): 229-234.
[6]	朱晓丽, 杨倩利, 王博, 拓胜军, 赵雪丽, 李静, 成胜全, 刘丽文. 儿童肥厚型心肌病中Noonan综合征基因型与临床表型[J]. 临床儿科杂志, 2023, 41(2): 125-129.
[7]	陈艳华, 尹丹, 郑敏, 吕铁伟, 易岂建, 李谧, 向平. 经导管介入封堵治疗儿童动脉导管未闭合并二尖瓣反流疗效评价[J]. 临床儿科杂志, 2022, 40(7): 517-521.
[8]	陈瑜, 徐维虹, 汪思园. 先天性心脏病患儿体外循环后发生低体温风险的列线图模型建立与评价[J]. 临床儿科杂志, 2021, 39(9): 682-.
[9]	陈颖慧，张琪. 调控动脉导管闭合的分子机制研究进展[J]. 临床儿科杂志, 2021, 39(11): 869-.
[10]	王桂喜,孙锟,孔令晖,等. SNParray分析技术在胎儿先天性心脏病诊断中的价值[J]. 临床儿科杂志, 2021, 39(10): 726-.
[11]	周云国，张政，许飞，等. 应用室间隔缺损封堵器治疗婴幼儿特殊形状动脉导管未闭疗效观察[J]. 临床儿科杂志, 2020, 38(9): 679-.
[12]	傅行鹏，叶菁菁，俞劲，等. 先天性心脏病合并感染性心内膜炎42 例患儿超声分析[J]. 临床儿科杂志, 2020, 38(2): 129-.
[13]	王智利，罗斯颖，易茜，等. CPAP 在先天性心脏病合并重症肺炎心功能不全患儿中的应用[J]. 临床儿科杂志, 2020, 38(1): 10-.
[14]	王野峰，胡原，杨舟，等. 儿童先天性心脏病合并心肌致密化不全的介入治疗及随访分析[J]. 临床儿科杂志, 2020, 38(1): 49-.
[15]	徐蒙蒙，徐月娟，陈　笋，等. 内脏异位综合征患儿中DNAI1 和DNAH5 基因编码区突变分析[J]. 临床儿科杂志, 2019, 37(7): 494-.